搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Ashbya gossypii 3-isopropylmalate dehydrogenase (LEU2) CSB-YP530103DOT
CSB-EP530103DOT
CSB-BP530103DOT
CSB-MP530103DOT
CSB-EP530103DOT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Anucleate primary sterigmata protein B (apsB), partial CSB-YP530104EKF
CSB-EP530104EKF
CSB-BP530104EKF
CSB-MP530104EKF
CSB-EP530104EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Actin-like protein arp10 (arp10) CSB-YP530105SXV
CSB-EP530105SXV
CSB-BP530105SXV
CSB-MP530105SXV
CSB-EP530105SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATPase family gene 2 protein (afg2), partial CSB-YP530106SXV
CSB-EP530106SXV
CSB-BP530106SXV
CSB-MP530106SXV
CSB-EP530106SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Putative 37S ribosomal protein S4-like (SPBC13G1.01c) CSB-YP530107SXV
CSB-EP530107SXV
CSB-BP530107SXV
CSB-MP530107SXV
CSB-EP530107SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Palmitoyltransferase swf1 (swf1), partial CSB-YP530108SXV1
CSB-EP530108SXV1
CSB-BP530108SXV1
CSB-MP530108SXV1
CSB-EP530108SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Probable ubiquitin carboxyl-terminal hydrolase 12 (ubp12), partial CSB-YP530109SXV
CSB-EP530109SXV
CSB-BP530109SXV
CSB-MP530109SXV
CSB-EP530109SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C1494.09c (SPCC1494.09c) CSB-YP530110SXV
CSB-EP530110SXV
CSB-BP530110SXV
CSB-MP530110SXV
CSB-EP530110SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe 54S ribosomal protein L24, mitochondrial (mrpl24), partial CSB-YP530111SXV
CSB-EP530111SXV
CSB-BP530111SXV
CSB-MP530111SXV
CSB-EP530111SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C14F5.01 (SPBC14F5.01, SPBC1861.10) CSB-YP530112SXV
CSB-EP530112SXV
CSB-BP530112SXV
CSB-MP530112SXV
CSB-EP530112SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized amino-acid permease C15C4.04c (SPBC15C4.04c), partial CSB-YP530113SXV
CSB-EP530113SXV
CSB-BP530113SXV
CSB-MP530113SXV
CSB-EP530113SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized RING finger protein C16G5.03 (SPBC16G5.03) CSB-YP530114SXV
CSB-EP530114SXV
CSB-BP530114SXV
CSB-MP530114SXV
CSB-EP530114SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C16G5.13 (SPBC16G5.13) CSB-YP530115SXV
CSB-EP530115SXV
CSB-BP530115SXV
CSB-MP530115SXV
CSB-EP530115SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Serine/threonine-protein kinase ppk23 (ppk23) CSB-YP530116SXV
CSB-EP530116SXV
CSB-BP530116SXV
CSB-MP530116SXV
CSB-EP530116SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C18H10.20c (SPBC18H10.20c) CSB-YP530117SXV
CSB-EP530117SXV
CSB-BP530117SXV
CSB-MP530117SXV
CSB-EP530117SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Bouquet formation protein 4 (bqt4) CSB-YP530118SXV
CSB-EP530118SXV
CSB-BP530118SXV
CSB-MP530118SXV
CSB-EP530118SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Septin homolog spn7 (spn7) CSB-YP530119SXV
CSB-EP530119SXV
CSB-BP530119SXV
CSB-MP530119SXV
CSB-EP530119SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Thiamine-repressible acid phosphatase SPBC21H7.03c (SPBC21H7.03c) CSB-YP530120SXV
CSB-EP530120SXV
CSB-BP530120SXV
CSB-MP530120SXV
CSB-EP530120SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Protein N-terminal amidase (nta1) CSB-YP530121SXV
CSB-EP530121SXV
CSB-BP530121SXV
CSB-MP530121SXV
CSB-EP530121SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe S-adenosylmethionine synthase (sam1) CSB-YP530122SXV
CSB-EP530122SXV
CSB-BP530122SXV
CSB-MP530122SXV
CSB-EP530122SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結(jié)出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結(jié)了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>